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Abstract
Background: The objectives of this study were to determine the prevalence and colonisation of Candida species and to
study the factors related to candidal colonisation in the oral cavity among type II diabetic patients. Methods: The data
of 102 diabetic patients was collected from the Outpatient Diabetic Clinic at the Naresuan University Hospital. Data
was collected via a questionnaire and oral examination. The subjects were measured for their fasting blood sugar levels
and salivary pH. Candida colonisation was assessed using saliva sampling, and was cultured on CHROMagar Candida
plates. Species and colony forming unit/mL were recorded. Results: The results showed that the prevalence of oral
Candida species in diabetic patients was 73.5%. The most frequent candidal species in diabetics were Candida albicans
(68.6%), followed by C. glabrata (28.4%), C. tropicalis (10.8%), and C. krusei (2.0%) respectively. There was no
statistical significance between the fasting plasma glucose levels and oral Candida species colonisation. Logistic
regression showed that a decrease of the salivary pH was related to the colonisation of candidal species. Results showed
that the use of a dental prosthesis was a related factor to the colonisation of candidal species (p < 0.05). Conclusions: A
high prevalence of candidal species were found in type II diabetic patients. Salivary pH and use of a dental prosthesis
are factors that promote candidal infections in type II diabetic patients.
Keywords: Candida, denture, diabetes mellitus oral health, oral thrush

Introduction
Diabetes mellitus (DM) is a chronic metabolic disorder
that is fast becoming one of the most important chronic
diseases worldwide. It has been estimated that the
number of adults with diabetes in the world will rise to
300 million by the year 2025.1 The relationship between
diabetes and oral candidiasis has been extensively studied
in scientific literature, particularly because diabetic
patients are more susceptible to fungal infections than
those without diabetes.2-3,8,11 Yeast adhesion to epithelial
cell surfaces is recognised as an essential first step in the
process of Candida colonisation and subsequent
infection.12 Salivary glucose levels in diabetic patients
favours yeast growth, owing to increased numbers of
available receptors for Candida.13

virus, those with nutritional deficiencies, malignancies,
or with metabolic disorders such DM.1
The role of Candida in the oral cavity of diabetic
patients is a controversial issue as the prevalence of the
microorganism in these patients varies greatly from 1880%.2 These discrepancies are usually attributed to the
methodology used in the laboratory, the number and
characteristics of the subjects, and to the sampling
techniques used.3 Although C. albicans is the most
frequently found species, others like C. dubliniensis, C.
glabrata, C. tropicalis, or C. krusei are also involved in
colonisation and oral candidiasis.4
An exhaustive review of the scientific literature
revealed a lack of studies on the association between
Candida and DM in Thailand. As such, it was considered
important to carry out an investigation on Candida in
the oral cavities of Thai patients and study the factors
that may facilitate the increase of the microorganism
and further understand the relationship between the
pathogen and oral health. The objectives of this study
were to determine the prevalence and colonisation of
candidal species, such as C. albicans, C. krusei, C.

The Candida genus presents over 150 species, 10 of
which are responsible for infections in humans. Of these
species, Candida albicans is part of the normal microbiota
and is isolated in the greatest frequency from the oral
cavity in human beings. When the balance between the
host and the microorganism is altered, Candida becomes
pathogenous and oral candidiasis is manifested. As
such, it occurs in diverse populations especially those
individuals affected by the human immunodeficiency
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glabrata, and C. tropicalis, and to study the factors
related to candidal species colonisation in the oral cavity
among type II diabetic patients.

chlamydospores in corn meal agar. 11 Results were
also recorded of the growth that occurred at 42 and
45 °C in Sabouraud agar by adding sodium chloride
at 6.5%.11

Methods
This cross-sectional study was conducted on a sample of
102 outpatients at the Naresuan University Hospital
with a prior diagnosis of Type II DM. Patients were
required to be under current treatment at the hospital
and over 40 years of age. All individuals participated
voluntarily and gave signed consent via a form approved
by the Human Ethics Committee of Naresuan University
(IRB.455/57). The study excluded patients who had a
positive diagnosis of HIV, or those who were treated
with antifungals within the 30 days prior to the study.
The study population was categorised into controlled
and uncontrolled groups according to the level of
glycosylated haemoglobin (HbA1c). For the controlled
group, values equal to or below 7% were considered for
inclusions and for the uncontrolled group, values
above 7% were considered. 13 The soft tissue of the
oral cavity of each patient was examined in detail
with a dental mirror. Possible lesions suggesting
candidiasis were recorded, and samples were taken to
culture in CHROMagar Candida. Additionally, a
fasting blood sugar (FBS) sample was taken, along
with stimulated saliva and oral rinse samples. The
first permitted HbA1c and FBS measurements, the
second was used to determine pH and the salivary
flow rate, and the last was used to search for candida
species. The samples were taken between 07:00 and
10:00 hours.
Oral rinses were obtained from each patient using 10
mL of saline solution that was retained in the mouth for
30 seconds. It was then deposited into a sterile container
that was stored in a portable cooler at 4 °C, and transported to the laboratory in the Faculty of Dentistry,
Naresuan University, where it was immediately
processed. Each sample was homogenised in a vortex,
inoculated in CHROMagar Candida (CHRO Magar
Company, Paris, France), and incubated at 30 °C for
48 hours. Thereafter, the colony forming units (CFU)
were counted per mL. Preliminary identification of
the yeasts and candidal species was completed by
observing the growth in the CHRO Magar Candida. 3
The yeast strains that presented colours different from
green tonalities in the CHROMagar Candida were
subjected to API 20C Aux identification (bioMérieux;
Marcy-l'Etoile, France). Green colonies, which were
presumed to comprise of C. albicans or C. dubliniensis,
were subjected to different phenotypic tests that
included germ tube formation and production of
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The pH was determined as soon as the sample was
collected using pH paper. The oral health status of
each patient was measured using the decayedmissing-filled (DMF) index outlined by the WHO
criteria. A periodontal chart was completed, using the
community periodontal index (CPI), to assess the
patient’s periodontal state and to evaluate their
treatment needs. 14
All results were recorded in a database and analysis
was completed using the SPSS version 20.00 statistical
program. To measure the association between the
different variables the Chi square test was used, when
a relationship existed. Logistic regression was used
for factors relating to candidal species colonisation in
the oral cavity amongst type II diabetic patients.

Results
Of the 102 type II diabetes mellitus patients who
participated in the study, 32 were male and 70 were
female, with a mean age of 57.9 (±13.6). The mean
duration of DM in the subjects was 6.1 years (±3.3).
Fasting blood sugar, HbA1C, oral salivary pH,
duration of DM, number of teeth present, CPI, and
denture use of all subjects are outlined in Table 1.
The pH of the subject’s saliva ranged between 5.0
and 7.5, with a mean salivary pH of 6.2 (±0.6).
Gender, fasting blood glucose, and duration of
disease were not associated with Candida.
Oral examination revealed that the mean number of
decayed teeth was 4.1 (±2.1) teeth per person. The
mean number of missing teeth was 10.0 (±9.9) teeth
per person and the mean number of filled teeth were
1.2 (±2.3) teeth per person. Bleeding on probing was
noted in 88 subjects (86.3%), with 4-5 mm
periodontal pockets present in 44 patients (43.1%)
and 6 mm periodontal pockets present in 37 patients
(36.3%). Oral lesions were recorded in 19 patients
(18.6%) and removable prostheses were noted in 36
cases (35.3%). Results showed that the prevalence of
oral Candida species in diabetic patients was 73.5%.
The most frequent candidal species found were C.
albicans (68.6%), followed by C. glabrata (28.4%), C.
tropicalis (10.8%), and C. krusei (2.0%) respectively.
We found mixed candidal species in the saliva of
patients, as shown in Table 2. There were no statistically
significant differences between the prevalence of
candidal species in the control group and the uncontrolled
group.
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Table 1. Characteristics of the Oral Cavities of Both Groups of Diabetic Patients

Characteristic

Total
N = 102

Controlled
N = 38

Uncontrolled
N = 64

Fasting Blood Sugar (mean mg/decilitre)
The level of glycosylated haemoglobin (HbA1c)
Oral pH
Duration of DM
Number of teeth present (teeth/person)
CPI Code 0 (number of patients)
Code 1-4 (number of patients)
Denture Used (number of patients)

148.4 ± 55.1
7.9 ± 1.7
6.2 ± 0.6
6.1 ± 3.3
15.4 ± 2.6
14
88
52

98.5± 7.0
7.0 ± 1.6
7.0 ± 2.0
5.2 ± 2.7
16.3 ± 3.1
8
30
18

175.5 ± 51.8
8.2 ± 1.9
6.0 ± 2.5
6.5 ± 2.4
14.8 ± 2.4
9
58
34

Table 2. Species of Candida Isolated in Both Groups of Diabetic Patients

Oral Candida species
C. albicans
C. glabrata
C. albicans + C. glabrata
C. albicans + C. krusei
C. albicans + C. tropicalis
C. albicans + other
C. glabrata + other
C. albicans + C. glabrata + C. tropicalis
C. albicans + C. glabrata + other
C. albicans + C. krusei + C. glabrata + C. tropicalis
C. albicans + C. glabrata + C. tropicalis + other
No Candida species isolated

Total
(Number of
patients)
38
3
10
1
3
4
2
5
6
1
2
27
102

Controlled
(Number of
patients)
14
0
3
0
0
1
0
3
4
0
1
11
37

Uncontrolled
(Number of
patients)
24
3
7
1
3
3
2
2
2
1
1
16
65

Table 3. Logistic Regression for Candida Infections and its Related Factors

Oral Characteristic
Salivary pH
6.5-7.5 (ref)
<6.5
Denture used
No (ref)
Yes
Salivary flow rate
Normal (ref)
Hyposalivation

OR

38
38

2.61

1.03-6.52

0.041

50
52

3.71

1.01-13.81

0.048

42
60

2.54

0.95-4.65

0.869

Logistic regression analysis for Candida infections and
its related factors are outlined in Table 3. Use of a
denture prosthesis was a significant risk for candidal
infections (OR = 3.71) over those patients who did not
wear dentures (p < 0.05). Logistic regression analysis
showed that a salivary pH of < 6.5 was a significant risk
for Candida in the oral cavity, versus a salivary pH of >
6.5 (OR = 2.706; p < 0.05).
Makara J. Health Res.

Candida infection
Upper - Lower

n

p

Discussion
The prevalence of Candida species obtained from our
sample group was 74.8%, with the most frequent candidal
species found in diabetics being C. albicans (68.6%),
confirming the variability of the bacteria, which could
depend on social factors or the sampling technique. The
presence of Candida in the oral cavity of diabetic patients
December 2017 | Vol. 21 | No. 3
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has been extensively researched all over the world and has
resulted in quite diverse values.2,3 The prevalence of
Candida species found in this study is similar to a previous
study carried out in Thailand using the modified imprint
culture technique4, which found the most frequent
candidal species seen in diabetics was C. albicans
(81.3%). Similarly, multiple studies also indicate that C.
albicans is the most commonly isolated yeast in the oral
cavities of diabetic patients.1,3,15 The present study also
found a high prevalence of C. glabrata, C. tropicalis and
C. krusei in DM patients, results that are also consistent
with previous studies showing that species other than C.
albicans were more prevalent in diabetic patients than
their healthy counterparts.3,15 The higher incidence of
Candida prevalence in DM patients may be explained by
the fact that the normal oral flora is altered by the
endocrine abnormalities in DM. The apparent increase in
candidal colonisation in diabetic patients may be attributed
to the greater adherence of fungi to epithelial cells. This is
thought to be facilitated by the increased glucose content
in the saliva, a genetic susceptibility to infection, altered
cellular and humoral immune defence mechanisms, and
local factors such as poor blood supply.16
Khosravi et al.8 reported that the degree of yeast
colonisation in the oral cavity may be altered by levels of
blood glucose, however our study did not reveal any
statistically significant differences between the levels of
blood glucose and Candida colonisation in DM patients.
Diabetes mellitus is considered a risk factor for the
development of periodontal disease, especially in patients
with poor control of the disease.17 Results from this
research did not find an association between the DMF
index and the presence of yeasts. Additionally, this study
also didn’t find any statistical association between CPI
and glycaemic control. These results are similar to a study
carried out by Arrieta et al.18 in type I and II diabetic
patients, which reported that no relationship existed
between CPI and the metabolic control of the disease.
We found a high incidence of C. albicans in both diabetic
and non-diabetic control subjects with low salivary flow
rate and pH, results that are consistent with previous
studies.19 A low salivary flow rate may result in decreased
cleaning and dilution functions of saliva on the oral
mucosa. Results from the present study indicate that oral
yeast carriage is not significantly influenced by glycaemic
control, duration, or complications of diabetes, gender, or
age.9 However, Kadir et al. did report lower pH values in
diabetic patients when compared with non-diabetic
individuals.6 Candida species are aerobic organisms that
require sugar and a neutral to acidic pH for optimal
growth.20 In the current research, the salivary pH
variations were independent of glycaemic control, and as
such it was considered as a factor that would affect
Candida growth. The low reactivity of salivary IgA with
C. albicans cells, grown at acidic pH values, may help to
explain the association between acidic saliva and the
Makara J. Health Res.

carriage of Candida in the oral cavity, as well as with oral
candidiasis.21 The pH of saliva is a factor which may
influence the growth and carriage of C. albicans within
the human mouth, and oral thrush has been previously
associated with acidic saliva.22 Salivary dysfunction,
reduced salivary pH, and salivary hyperglycaemia can
provide a potential substrate for fungal growth in DM
patients.2
This study found that wearing a dental prosthesis was a
risk factor for Candida infections. A study carried out by
Abu in 1998, found a significant increase in the rate and
density of C. albicans in denture wearers of the diabetic
group compared with the non-diabetic controls.23
Research has demonstrated that candidal carriage is higher
amongst diabetics wearing dentures because C. albicans
adheres to acrylic and it has been suggested that dentures
behave as a reservoir for these yeasts.22,24 The decrease in
salivary pH, the increase in serum glucose, and wearing
dentures are all related to an increased rate and density of
C. albicans.6 Colonisation of the oral mucosa by candidal
species is a risk factor for progression to oral candidiasis,
in both immunocompetent and immunocompromised
individuals.25 Oral candidiasis is due to the proliferation of
fungi on the mucosal surface and it may come from the
microbiota of the same patient in a carrier state.26 Its
growth is explained by fungal mechanisms and the host’s
defences.27 The coexistence of different Candida species
in an infection makes it more persistent and difficult to
treat.28
The diversity of isolated Candida species in the oral
cavities of diabetic subjects, and the association between
poorly controlled diabetes and species other than C.
albicans, which generally present less sensitivity to
antifungal medications, implies there is a need for further
studies to clearly establish the role of Candida in the oral
cavities of type II diabetic patients.
The limitations of this study were its small sample size, of
only 102 patients, and that the majority of the subjects had
type II diabetes mellitus. There is need to perform similar
research in larger numbers of diabetic subjects including
those with type I diabetes mellitus. Additionally, there is a
need to assess various alternative treatment protocols that
are equally effective against C. albicans and other
candidal species especially that of C. glabrata.

Conclusions
There was a high prevalence of candidal species found in
type II diabetic patients. Salivary pH and the use of a
dental prosthesis were risk factors that appeared to
promote Candida infections in type II diabetic patients.
Further knowledge about the prevalence of species
distribution, rapid species identification, antifungal
susceptibility testing, and the development of new
antifungal medications are necessary to achieve a decrease
December 2017 | Vol. 21 | No. 3

A Cross-Sectional Study of the Candidal Species Isolated in the Oral Cavities 103

in Candida infections and an increase in the quality of life
of denture wearing individuals with type II diabetes
mellitus.
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